Company RELIEF THERAPEUTICS Holding SA CINNOBER BOAT
Equities
0QKQ
CH0100191136
Biotechnology & Medical Research
Business Summary
Sales per Business
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Products
100.0
%
| 6 | 100.0 % | 6 | 100.0 % | -0.79% |
Sales per region
CHF in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe (excluding Switzerland)
47.8
%
| 2 | 39.7 % | 3 | 47.8 % | +19.65% |
North America
23.3
%
| 2 | 27.9 % | 1 | 23.3 % | -17.25% |
Rest of the World
22.0
%
| 1 | 19.2 % | 1 | 22.0 % | +13.42% |
Switzerland
6.9
%
| 1 | 13.2 % | 0 | 6.9 % | -48.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 45 | 16-05-24 |
Michelle Lock
BRD | Director/Board Member | 55 | 22-01-27 |
Anthony M. Kim
PRN | Corporate Officer/Principal | - | 21-11-30 |
Paolo Galfetti
PRN | Corporate Officer/Principal | 59 | 21-05-26 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ram Selvaraju
CHM | Chairman | 45 | 16-05-24 |
Paolo Galfetti
PRN | Corporate Officer/Principal | 59 | 21-05-26 |
Michelle Lock
BRD | Director/Board Member | 55 | 22-01-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,040,837 | 9,570,182 ( 68.16 %) | 1,500,398 ( 10.69 %) | 68.16 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
1,822,398 | 12.98% | 2,555,385 $ |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+38.36% | 52.5B | |
+36.73% | 39.31B | |
-8.63% | 39.01B | |
+25.46% | 28.2B | |
-11.17% | 26.57B | |
+11.44% | 26.2B | |
+45.09% | 14.15B | |
+32.93% | 12.62B | |
-5.30% | 11.74B |